Moderna, the American pharma company that became popular for its COVID vaccine, has spent three days trading like a meme stock. Shares exploded 177% on Wednesday after its personalized mRNA cancer vaccine with Merck succeeded in a Phase 3 melanoma trial, adding roughly $30 billion in market value in
Source: BeInCrypto